Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 16Unknown 9Recruiting 6Active not recruiting 6Terminated 5Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Pancreatic Neoplasms 6Resectable Pancreatic Cancer 1Locally Advanced Pancreatic Adenocarcinoma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 42130-nm albumin-bound paclitaxel 26Albumin-Bound Paclitaxel 18Irinotecan 16Oxaliplatin 14Fluorouracil 14pembrolizumab 13Nivolumab 13Magnetic Resonance Spectroscopy 11Leucovorin 11Taxes 10Specimen Handling 9Biopsy 9Cisplatin 8Capecitabine 7folfirinox 6Radiotherapy 6Carboplatin 6irinotecan sucrosofate 5durvalumab 5Ipilimumab 5Cyclophosphamide 5olaparib 4defactinib 4Surveys and Questionnaires 4Standard of Care 4Radiosurgery 4Immunoglobulin G 4Disulfides 4dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Pancreatic Neoplasms × folfirinox × Clear all
NCT04594772 2026-06-01

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

University of Cincinnati

Phase 2 Active not recruiting
32 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04589234 2026-05-14

Saltikva for Metastatic Pancreatic Cancer

Salspera LLC

Phase 2 Active not recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07243288 2025-11-21

RADIOPAN

Assistance Publique - Hôpitaux de Paris

Active not recruiting
400 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05360732 2025-11-13

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

Fox Chase Cancer Center

Phase 2 Active not recruiting
37 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Active not recruiting
168 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05121038 2024-12-17

CENDIFOX

University of Kansas Medical Center

Phase 1/2 Active not recruiting
50 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡